Zenas BioPharma, Inc. Balance Sheet
Zenas BioPharma, Inc.'s total assets for Q3 2025 were $322.02M, an increase of 9.87% from the previous quarter. ZBIO total liabilities were $125.59M for the fiscal quarter, a 134.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.